Universal Influenza Vaccine Update

Published Online: Monday, January 28, 2013
Follow Pharmacy_Times:
In this video, recorded at ICAAC 2012, the American Society for Microbiology’s annual infectious diseases meeting, Jeff Fox, PhD, features editor of Microbe, talks with Donna Ambrosino and Zachary Shriver of Visterra Inc about efforts to develop a universal influenza vaccine that will be capable of protecting against any potential strain of the influenza virus. Currently, the influenza vaccine must be updated annually to protect against the strains of influenza expected to circulate in a given year, leaving people vulnerable to novel virus strains.

Related Articles
In a large-scale trial, Sanofi’s Fluzone High-Dose vaccine demonstrated efficacy in preventing influenza specifically in adults aged 65 years or older.
An ongoing shortage of intravenous saline solution has forced health care workers to spend extra time and funds tracking it down and, in some cases, has caused patient treatment to be delayed.
Latest Issues
$auto_registration$